中文 | English
Return
Total: 47 , 1/5
Show Home Prev Next End page: GO
Author:(Wenhu LI)

1.A 30-year review and outlook on esophageal acid and pressure measurement

Yong JIANG ; Wentao FANG ; Zhigang LI ; Wenhu CHEN ; Wenhu PAN ; Yanfang ZHENG ; Hong ZHANG ; Yuchen SU ; Jie ZHANG

Chinese Journal of Clinical Thoracic and Cardiovascular Surgery 2025;32(06):766-770

2.Pericyte activation accompanied by peritubular capillaries dysfunction and pericyte-to-myofibroblast transition is associated with renal fibrosis in diabetic nephropathy

Yiduo FENG ; Dongli TIAN ; Yu BAI ; Yan LI ; Liling ZHANG ; Yiru WU ; Wenhu LIU ; Zongli DIAO

Kidney Research and Clinical Practice 2025;44(6):928-940

3.Analysis of factors influencing elevated blood pressure and overweight/obesity and their comorbidities among Tibetan middle school students in Lhasa City

LIAN Qiguo, CI Renyangzong, WANG Yanhui, ZHAO Junmei, LU Yuxin, LI Na, ZHAO Wenhu, DENG Liping, LIU Zhihao

Chinese Journal of School Health 2024;45(3):423-426

4.The mediating effect of self-efficacy between the self-management behavior and family support in rural patients with type 2 diabetes mellitus

Chaofan HE ; Xuefeng ZHONG ; Xinyu MA ; Liangchun JIA ; Minglong LI ; Wenhu CUI ; Zan XU

Chinese Journal of Behavioral Medicine and Brain Science 2024;33(12):1116-1121

5.The mediating effect of self-efficacy between the self-management behavior and family support in rural patients with type 2 diabetes mellitus

Chaofan HE ; Xuefeng ZHONG ; Xinyu MA ; Liangchun JIA ; Minglong LI ; Wenhu CUI ; Zan XU

Chinese Journal of Behavioral Medicine and Brain Science 2024;33(12):1116-1121

6.Research progress on"one-two punch"strategy in the therapy of glioma

Kui ZHANG ; Kai ZHAO ; Wenhu LI ; Minhao HUANG ; Ninghui ZHAO

Chinese Journal of Clinical Oncology 2023;50(21):1106-1109

7.miR-216b-5p mediates autophagy to reverses cisplatin resistance of esophageal cancer Eca109 cells by targeting ATG5

QIU Shanting ; LI Xiaoyan ; CHEN Zhecong ; GAO Mengyuan ; JIN Shuyi ; CHEN Wenhu

Chinese Journal of Cancer Biotherapy 2023;30(7):552-559

8.Preclinical and early clinical studies of a novel compound SYHA1813 that efficiently crosses the blood-brain barrier and exhibits potent activity against glioblastoma.

Yingqiang LIU ; Zhengsheng ZHAN ; Zhuang KANG ; Mengyuan LI ; Yongcong LV ; Shenglan LI ; Linjiang TONG ; Fang FENG ; Yan LI ; Mengge ZHANG ; Yaping XUE ; Yi CHEN ; Tao ZHANG ; Peiran SONG ; Yi SU ; Yanyan SHEN ; Yiming SUN ; Xinying YANG ; Yi CHEN ; Shanyan YAO ; Hanyu YANG ; Caixia WANG ; Meiyu GENG ; Wenbin LI ; Wenhu DUAN ; Hua XIE ; Jian DING

Acta Pharmaceutica Sinica B 2023;13(12):4748-4764

9.Smart drug delivery systems for precise cancer therapy.

Xiaoyou WANG ; Chong LI ; Yiguang WANG ; Huabing CHEN ; Xinxin ZHANG ; Cong LUO ; Wenhu ZHOU ; Lili LI ; Lesheng TENG ; Haijun YU ; Jiancheng WANG

Acta Pharmaceutica Sinica B 2022;12(11):4098-4121

10.Enrichment of Wee1/CDC2 and NF-κB Signaling Pathway Constituents Mutually Contributes to CDDP Resistance in Human Osteosarcoma

Zhengbo HU ; Lugen LI ; Wenxing LAN ; Xiao WEI ; Xiangyuan WEN ; Penghuan WU ; Xianliao ZHANG ; Xinhua XI ; Yufa LI ; Liqi WU ; Wenhu LI ; Xiaohong LIAO

Cancer Research and Treatment 2022;54(1):277-293

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 47 , 1/5 Show Home Prev Next End page: GO